Search results
Pfizer Inc (PFE) Q1 2024 Earnings Call Transcript Highlights: Na
Guru Focus· 3 days agoTotal Revenue: $14.9 billion, operational decline of 19% year-over-year.Oncology Revenue: Grew 19% operationally, driven by acquisitions and product launches.A
Pfizer earnings beat by $0.29, revenue topped estimates By Investing.com
Investing.com· 3 days agoPfizer earnings beat by $0.29, revenue topped estimates
Pfizer (PFE) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 2 days agoImage source: The Motley Fool. Pfizer (NYSE: PFE) Q1 2024 Earnings Call May 01, 2024, 10:00 a.m. ET Contents: Prepared Remarks Questions and Answers Call...
NHS to provide Pfizer’s Voxelotor to treat sickle cell disease
Pharmaceutical Technology via Yahoo Finance· 23 hours agoThe UK's National Health Service (NHS) has announced plans to offer Pfizer's Voxelotor (Oxbryta), a...
Q1 2024 Pfizer Inc Earnings Call Transcript
Guru Focus· 3 days agoMay 01, 2024 / 02:00PM GMTOperator Good day, everyone, and welcome to Pfizer's First Quarter 2024 Earnings Conference Call. Today's call is being recorded. At t
Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims
Zacks· 1 day agoEli Lilly (LLY), Novo Nordisk (NVO), Pfizer (PFE) and AbbVie (ABBV) announce their first-quarter results.
Here's Why Pfizer (PFE) is a Strong Momentum Stock
Zacks via Yahoo Finance· 20 hours agoUtilizing one-week price change and the monthly percentage change in earnings estimates, among other factors, the Momentum Style Score can help determine...
Pfizer Stock Jumps On 'Massive' Upside Thanks To Paxlovid Surprise
Investor's Business Daily· 3 days agoComirnaty, the Covid vaccine Pfizer developed with BioNTech (BNTX) brought in $354 million in sales,...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 3 days agoPfizer stock jumped to its 50-day moving average in early May after the company beat first-quarter...
Pfizer gene therapy made in NC gets FDA approval. It costs $3.5M per dose - Triangle Business...
The Business Journals· 5 days agoThe U.S. Food and Drug Administration has approved a gene therapy developed by Pfizer and...